CHARLES WYKOFF to Risk Factors
This is a "connection" page, showing publications CHARLES WYKOFF has written about Risk Factors.
Connection Strength
0.313
-
Loss to Follow-Up Among Patients With Proliferative Diabetic Retinopathy in Clinical Practice. Am J Ophthalmol. 2020 07; 215:66-71.
Score: 0.064
-
ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION: Role of Prophylactic Topical Ophthalmic Antibiotics. Retina. 2016 Jul; 36(7):1349-56.
Score: 0.049
-
What is the optimal timing for rhegmatogenous retinal detachment repair? JAMA Ophthalmol. 2013 Nov; 131(11):1399-400.
Score: 0.041
-
Preoperative evaluation for patients with choroidal/ciliary body melanomas: what is necessary? Am J Ophthalmol. 2011 Jun; 151(6):921-4.
Score: 0.035
-
Accurate prediction of disease-risk factors from volumetric medical scans by a deep vision model pre-trained with 2D scans. Nat Biomed Eng. 2025 Apr; 9(4):507-520.
Score: 0.022
-
Risk factors for development of hyper-reflective foci overlying drusen in eyes with intermediate age-related macular degeneration. Br J Ophthalmol. 2024 Aug 22; 108(9):1234-1239.
Score: 0.022
-
Predictive Factors Influencing the Evolution of Acquired Vitelliform Lesions in Intermediate Age-Related Macular Degeneration Eyes. Ophthalmol Retina. 2024 Sep; 8(9):863-871.
Score: 0.021
-
Risk Factors for the Development of Fellow Eye Horseshoe Retinal Tears Following Horseshoe Retinal Tear in the Presenting Eye. Ophthalmic Surg Lasers Imaging Retina. 2023 Jun; 54(6):338-345.
Score: 0.020
-
OCT Risk Factors for Development of Atrophy in Eyes with Intermediate Age-Related Macular Degeneration. Ophthalmol Retina. 2023 03; 7(3):253-260.
Score: 0.019
-
Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab: Findings from the TREX-AMD Trial. Ophthalmology. 2017 02; 124(2):215-223.
Score: 0.013
-
Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol. 2012 Jan; 153(1):162-6.e1.
Score: 0.009